D-Wave, Quantum

D-Wave Quantum: Two Securities Suits, a $20 Million University Sale and the Question of When an Order Becomes Revenue

Published on 11/16/2026 at 10:30 | Editorial boerse-global.de
Pomerantz and Rosen Law filed securities class actions against D-Wave and executives, questioning whether record order intake converted into revenue.
D-Wave Quantum Illustration mit AI erstellt.

Two separate law firms have now flagged securities class actions against D-Wave Quantum and certain of its executives, and both cases circle the same commercial question: whether the company's headline order intake ever translated into billable revenue. Pomerantz announced its filing yesterday, alleging violations of U.S. federal securities law, while Rosen Law Firm issued a reminder about its own previously filed suit. The stock slipped 2.4% on the day.

Pomerantz puts the class period at February 27 through August 25 and names both the company and individual officers as defendants. Its allegations are that D-Wave understated the time required for installations and revenue recognition, and overstated demand and the conversion of orders into sales. None of this has been established in court, and the plaintiff group has not yet been certified.

Rosen's claims drill into the same seam. According to that firm, the order intake D-Wave described as record-setting in 2026 rested predominantly on two contracts signed before the relevant investor period, meaning it demonstrated neither new nor expanded commercial use. The suit further alleges the company may not have been on track to convert its systems-sale pipeline into fresh bookings, with deliveries and the associated revenue possibly pushed into the fourth quarter of 2026 and into 2027. Those too are accusations, not findings.

The quarter that cut both ways

The operating picture underneath the litigation is mixed. D-Wave reported third-quarter 2026 revenue of $4.5 million on November 10, up 21% year over year — growth, certainly, but not an answer to whether larger systems sales will produce dependable income. The loss per share came in at $0.13, wider than expected, and operating expenses ran to $55.9 million. Net loss for the quarter was $48.197 million.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

Bookings tell a more awkward story. They fell 19% year over year in the quarter to $1.9 million, even as the first nine months of 2026 came in well above the prior-year level. That divergence puts the timing of contract closings under a spotlight: a single quarter's intake says little on its own, and a nine-month figure that leans on a handful of signatures says only a little more.

What would carry more weight is a traceable chain from installation to usage to recognized revenue. On that front there is one concrete data point — NTT DOCOMO has put a second production application into service. That documents additional use by an existing customer and is more informative than a bare performance claim, though it implies neither a specific revenue amount nor any commitment to further orders.

A $20 million test case

The systems sale announced January 27 to Florida Atlantic University, worth $20 million, offers the next visible checkpoint. A later statement indicated installation should begin before the end of 2026. A start on installation is not the same as fully recognized revenue, but it would show that a announced large deal has reached its next stage of execution. Confirmation of that start is the near-term item to watch; the timing of the matching revenue would remain open.

The bear case is not merely a soft stretch in the share price. If installations and revenue recognition slip, large reported order intake could sit for longer without corresponding sales, and the weaker quarterly bookings would sharpen the question of how reliably new contracts backfill. Growth in the top line alone does not establish economic viability at this stage of the company's development.

D-Wave Quantum at a turning point? This analysis reveals what investors need to know now.

Targets cut, ratings held

Analysts have adjusted their numbers without abandoning their stance. Jefferies trimmed its price target to $33 from $40 while keeping a buy rating. Craig-Hallum went further, cutting to $18 from $40 — and also stayed at buy.

On the legal calendar, December 15, 2026 is the deadline for motions to serve as lead plaintiff. That is a procedural step, not a ruling on the merits of any allegation. For the investment case, verifiable evidence of execution and revenue recognition remains the measure that matters.

Ad

D-Wave Quantum Stock: New Analysis - 16 November

Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated D-Wave Quantum analysis...

Disclaimer...
en | US26740W1099 | D-WAVE | boerse | 70520207 |